US Stock MarketDetailed Quotes

Halozyme Therapeutics (HALO)

Watchlist
  • 67.310
  • +0.330+0.49%
Close Apr 14 16:00 ET
  • 67.310
  • 0.0000.00%
Post 20:01 ET
7.97BMarket Cap26.29P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Halozyme Therapeutics (HALO) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
Research, development and commercialization of our proprietary enzymes and devices, Hypercon1.4B100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States822.98M58.93%
Switzerland276.41M19.79%
Belgium217.52M15.57%
Japan46.37M3.32%
All Other Foreign33.33M2.39%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
At 22:00 Beijing time on April 13, the US Central Command officially blocked maritime traffic at Iranian ports, imposing the strictest sanct Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -